Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)
- Conditions
- Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
- Interventions
- Procedure: Magnetic Resonance ImagingProcedure: Computed TomographyOther: Best PracticeOther: Virtual Technology InterventionOther: Questionnaire Administration
- Registration Number
- NCT05600556
- Lead Sponsor
- Thomas Jefferson University
- Brief Summary
This clinical trial explores if using virtual reality (VR) headsets will help to improve patient understanding of their disease and decrease anxiety about treatment. Three-dimensional (3D) images may help the patient visualize their tumor and location better and therefore understand potential side effects. Visualizing a virtual representation of the magnetic resonance imaging (MRI) linear accelerator (Linac) may decrease treatment related anxiety.
- Detailed Description
PRIMARY OBJECTIVE:
I. Examine patient reported comprehension of their tumor characteristics and treatment plan following 3D virtual reality review of their imaging.
SECONDARY OBJECTIVE:
I. Examine patient reported treatment related anxiety prior to and following virtual reality (VR) simulation of the MRI Linac treatment process.
OUTLINE: Patients are assigned to 1 of 2 cohorts.
COHORT I: Patients receive two-dimensional (2D) image review using standard computer screen on study. Patients undergo MRI and computed tomography (CT) imaging at screening and on study.
COHORT II: Patients receive image review using virtual reality stimulation on study. Patients also view MRI treatment room using virtual reality stimulation. Patients undergo MRI and CT imaging at screening and on study.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Age: above 18 years
- Participants must be histologically proven neoplasm
- Planned to undergo radiation treatment using the MR Linac
- Inability to tolerate virtual reality headset
- Non-English speaking patients
- Pediatric patients are ineligible
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Cohort I (standard imaging) Best Practice Patients receive 2D image review using standard computer screen on study. Patients undergo MRI and CT imaging at screening and on study Cohort I (standard imaging) Computed Tomography Patients receive 2D image review using standard computer screen on study. Patients undergo MRI and CT imaging at screening and on study Cohort II (virtual reality) Magnetic Resonance Imaging Patients receive image review using virtual reality stimulation on study. Patients also view MRI treatment room using virtual reality stimulation. Patients undergo MRI and CT imaging at screening and on study Cohort II (virtual reality) Computed Tomography Patients receive image review using virtual reality stimulation on study. Patients also view MRI treatment room using virtual reality stimulation. Patients undergo MRI and CT imaging at screening and on study Cohort I (standard imaging) Magnetic Resonance Imaging Patients receive 2D image review using standard computer screen on study. Patients undergo MRI and CT imaging at screening and on study Cohort II (virtual reality) Virtual Technology Intervention Patients receive image review using virtual reality stimulation on study. Patients also view MRI treatment room using virtual reality stimulation. Patients undergo MRI and CT imaging at screening and on study Cohort II (virtual reality) Questionnaire Administration Patients receive image review using virtual reality stimulation on study. Patients also view MRI treatment room using virtual reality stimulation. Patients undergo MRI and CT imaging at screening and on study Cohort I (standard imaging) Questionnaire Administration Patients receive 2D image review using standard computer screen on study. Patients undergo MRI and CT imaging at screening and on study
- Primary Outcome Measures
Name Time Method Increase in composite knowledge questionnaire score At first on treatment visit (after starting radiation) Pre- and post-intervention knowledge summary scores and anxiety scores will be summarized using means, standard deviations, and ranges. Average change will be estimated for each group along with 95% confidence intervals and the difference between groups will be estimated with a 95% confidence interval.
- Secondary Outcome Measures
Name Time Method General anxiety At first on treatment visit (after starting radiation) Post-intervention knowledge summary scores and anxiety scores will be summarized using means, standard deviations, and ranges. Average change will be estimated for each group along with 95% confidence intervals and the difference between groups will be estimated with a 95% confidence interval.
MRI specific anxiety Baseline and after MRI scan at time of planning scan Pre- and post-intervention knowledge summary scores and anxiety scores will be summarized using means, standard deviations, and ranges. Average change will be estimated for each group along with 95% confidence intervals and the difference between groups will be estimated with a 95% confidence interval.
Plan review understanding Baseline and at first on treatment visit (after starting radiation) Pre- and post-intervention knowledge summary scores and anxiety scores will be summarized using means, standard deviations, and ranges. Average change will be estimated for each group along with 95% confidence intervals and the difference between groups will be estimated with a 95% confidence interval.
Trial Locations
- Locations (1)
Sidney Kimmel Cancer Center at Thomas Jefferson University
🇺🇸Philadelphia, Pennsylvania, United States